Controlled release of recombinant human bone morphogenetic protein-7 in nanoscaffolds

Nanomedicine

Volumn 2, Issue 3, 2007, Pages 385-390

  Tan, Ken Jin ^a   Liao, Susan ^a,b   Chan, Casey K ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Bone morphogenetic protein; Drug delivery; Nanofibrous scaffold; Nanosphere; Osteogenesis; Osteoinduction

Indexed keywords

ANTINEOPLASTIC AGENT; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; COLLAGEN SPONGE; INFUSE; MOLECULAR SCAFFOLD; NANOPARTICLE; NANOSPHERE; POLYGLACTIN; POLYLACTIC ACID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BONE DEVELOPMENT; BONE TRANSPLANTATION; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; FRACTURE HEALING; HUMAN; LUNG TUMOR; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OVARY TUMOR; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION; REVIEW; SPINE FUSION; TISSUE ENGINEERING;

EID: 34250355162     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/17435889.2.3.385     Document Type: Review

References (27)

1. Wei GB, Jin Q, Giannobile WV, Ma PX: The enhancement of osteogenesis by nano-fi brous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28, 2087-2096 (2007).
2. Arrington ED, Smith WJ, Chambers HG et al.: Complications of iliac crest bone graft harvesting. Clin. Orthop. 329. 300-309 (1996).
3. Banwart JC, Asher MA, Hassanein RS: Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine 20, 1055-1060 (1995).
4. Fernyhough JC, Schimandle H, Weigel MC et al.: Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine 17, 1474-1480 (1992).
5. Govender S, Csimma C, Genant HK et al.: Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective randomized study of four hundred and fifty patients. J. Bone Joint Surg. Am. 84A. 2123-2134 (2002).
6. Friedlaender GE, Perry CR, Cole JD et al.: Osteogenic protein-1 in the treatment of tibial nonunions. J. Bone Joint Surg. Am. 83A(S1), 151-158 (2001).
7. Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA: Clinical and radiologic outcomes of anterior lumbar interbody fusion using recombinant human bone porphogenetic protein-2. Spine 27(21), 2396-2408 (2002).
8. Wang EA, Rosen V, D'Alessandro JS et al.: Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl Acad. Sci. USA 87, 2220-2224 (1990).
9. Yoshikawa H, Rettig WJ, Lane JM et al.: Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas. Cancer 74, 842-847 (1994).
10. Katoh M, Terada M: Overexpression of bone morphogenetic protein (BMP)-4 mRNA in gastric cancer cell lines of poorly differentiated type. J. Gastroenterol. 31, 137-139 (1996).
11. Kleeff J, Maruvama H, Ishiwata T et al.: Bone morphogenetic protein-2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer. Gastroenterology 116, 1202-1216 (1999).
12. Ide H, Yoshida T, Matsumoto N et al.: Growth regulation of human prostate cancer cells by bone morphogenetic protein. Cancer Res. 57, 5022-5027 (1997).
13. Soda H, Raymond E, Sharma S et al.: Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units. Anticancer Drugs 9, 327-331 (1998).
14. Tada A, Nishihara T, Kato H: Bone morphogenetic protein-2 suppresses the transformed phenotype and restores actin monofilaments of human lung carcinoma A549 cells. Oncol. Rep. 5, 1137-1140 (1998).
15. Kanatani M, Sugimoto T, Kaji H et al.: Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J. Bone Miner. Res. 10, 1681-1690 (1995).
16. Lane JM: BMPs: why are they not in everyday use? J. Bone Joint Surg. Am. 83(Suppl. 1), 161-162 (2001).
17. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J: Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J. Biomed. Mater. Res. 46(2), 193-202 (1999).
18. Uludag H, Freiss W, Williams D et al.: rh-BMP-collagen sponges are osteoconductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rh-BMP pharmacokinetics. Ann. NY Acad. Sci. 875, 369-378 (1999).
19. Seeherman H, Wozney J, Li R: Bone morphogenetic protein delivery systems. Spine 27(16S), S16-S24 (2002).
20. Feng SS: New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Nanomedicine 1(3), 297-309 (2006).
21. Li C, Vepari C, Jin HJ, Kim HJ, Kaplan DL: Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27, 3115-3124 (2006).
22. Steinmuller-Nethl D, Kloss FR, Najam-ul-Haq M et al.: Strong binding of BMP-2 to nanocrystalline diamond by physisorption. Biomaterials 27, 4527-4556 (2006).
23. Chan CK, Kumar TSS, Liao S et al.: Biomimietic nanocomposites for bone graft applications. Nanomedicine 1(2), 177-188 (2006).
24. Li WJ, Shanti RM, Tuan RS: Tissue, cell and organ engineering. In: Electrospinning Technology for Nanofibrous Scaffolds in Tissue Engineering. Nanotechnologies for the Life Sciences (Volume 9). Wiley-VCH Verlag GmbH & Co, Germany 135-187 (2007).
25. Wei GB, Pettway GJ, McCauley LK, Ma PX: The release profiles and bioactivity of parathyroid hormone from poly (lactic-co-glycolic acid) microspheres. Biomaterials 25(2), 345-352 (2004).
26. Wei G, Jin Q, Giannobile WV, Ma PX: Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J. Control. Release 112(1), 103-110 (2006).
27. Wei GB, Ma PX: Macro-porous and nano-fibrous polymer scaffolds and polymer/bone-like apatite composite scaffolds generated by sugar spheres. J. Biomed. Mater. Res. 78, 306-315 (2006).